Medical science and legislation are colliding on Capitol Hill over the development of biologic drugs. On the medical side is a complex science that uses unique living tissue to create new and effective treatments. On the legislative side is the hope of making lower-cost follow-on biologies (FOBs) available to a larger number of patients - a clear case of legislation trying to catch up with science.
展开▼
